{"transactions":[{"id":790545,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2026-05-06T20:10:45.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of May 4, 2027, May 4, 2028 and May 4, 2029."}],"balance_after":104000,"derivative":{"exercise_price":2.25,"exercise_date":"2027-05-04","expiration_date":"2036-05-04","underlying":"Common Stock","underlying_shares":104000},"source":{"system":"sec-edgar","filing":"0001042167-26-000039","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216726000039/primary_doc.xml","form_type":"4"}},{"id":976919,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2025-12-09T16:28:19.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of December 5, 2026, December 5, 2027 and December 5, 2028."}],"balance_after":4000,"derivative":{"exercise_price":2.49,"exercise_date":"2026-12-05","expiration_date":"2035-12-05","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001042167-25-000066","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216725000066/primary_doc.xml","form_type":"4"}},{"id":1025810,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2025-10-03T21:06:21.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of October 1, 2026, October 1, 2027 and October 1, 2028."}],"balance_after":6000,"derivative":{"exercise_price":3.89,"exercise_date":"2026-10-01","expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001042167-25-000047","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216725000047/primary_doc.xml","form_type":"4"}},{"id":1155546,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2025-05-08T18:56:57.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of May 6, 2026, May 6, 2027 and May 6, 2028."}],"balance_after":30000,"derivative":{"exercise_price":0.5021,"exercise_date":"2026-05-06","expiration_date":"2035-05-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001042167-25-000025","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216725000025/primary_doc.xml","form_type":"4"}},{"id":1314440,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock, par value $0.001","published_at":"2025-01-03T21:20:13.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":49383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service.  The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions.  Vested shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total holdings include 58,047 shares underlying deferred restricted stock units."}],"balance_after":61273,"source":{"system":"sec-edgar","filing":"0001415889-25-000428","document":"form4-01032025_040107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000141588925000428/form4-01032025_040107.xml","form_type":"4"}},{"id":1395642,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2024-10-02T20:37:47.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of October 1, 2025, October 1, 2026 and October 1, 2027."}],"balance_after":70000,"derivative":{"exercise_price":0.7661,"exercise_date":"2025-10-01","expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001042167-24-000062","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216724000062/primary_doc.xml","form_type":"4"}},{"id":1439179,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2024-08-07T19:56:21.000Z","date":"2024-08-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of August 6, 2025, August 6, 2026 and August 6, 2027."}],"balance_after":20000,"derivative":{"exercise_price":0.8111,"exercise_date":"2025-08-06","expiration_date":"2034-08-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001042167-24-000056","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216724000056/primary_doc.xml","form_type":"4"}},{"id":1691995,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2024-01-03T21:55:23.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Total holdings include 8,664 shares underlying deferred restricted stock units."}],"balance_after":11890,"source":{"system":"sec-edgar","filing":"0001104659-24-000915","document":"tm241755-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924000915/tm241755-9_4seq1.xml","form_type":"4"}},{"id":1737782,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2023-11-17T22:51:17.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of October 2, 2024, October 2, 2025 and October 2, 2026."}],"balance_after":80000,"derivative":{"exercise_price":0.73,"exercise_date":"2024-10-02","expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001042167-23-000065","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216723000065/primary_doc.xml","form_type":"4"}},{"id":1897369,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2023-05-11T21:54:46.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of May 9, 2024, May 9, 2025 and May 9, 2026."}],"balance_after":10000,"derivative":{"exercise_price":1.37,"exercise_date":"2024-05-09","expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001042167-23-000029","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216723000029/primary_doc.xml","form_type":"4"}},{"id":2016125,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-02-14T21:09:02.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":11976,"price":0.835,"value":9999.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total holdings include 50,000 shares underlying deferred restricted stock units."}],"balance_after":133379,"source":{"system":"sec-edgar","filing":"0001104659-23-021614","document":"tm236803-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465923021614/tm236803-3_4seq1.xml","form_type":"4"}},{"id":2067009,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-01-05T02:27:43.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January1, 2024, 2025 and 2026, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the reporting person's termination of service, or earlier upon her death or change in control of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 50,000 shares underlying deferred restricted stock units."}],"balance_after":121403,"source":{"system":"sec-edgar","filing":"0001104659-23-001102","document":"tm231728-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465923001102/tm231728-8_4seq1.xml","form_type":"4"}},{"id":2081462,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-12-19T13:50:26.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of December 16, 2023, December 16, 2024 and December 16, 2025."}],"balance_after":71403,"source":{"system":"sec-edgar","filing":"0001104659-22-128075","document":"tm2232939-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465922128075/tm2232939-2_4seq1.xml","form_type":"4"}},{"id":2124839,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2022-11-04T21:39:32.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options are annual award grants for fiscal 2023 and options for one-third of the shares vest on each of November 2, 2023, November 2, 2024 and November 2, 2025."}],"balance_after":90000,"derivative":{"exercise_price":11.46,"exercise_date":"2023-11-02","expiration_date":"2032-11-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001042167-22-000064","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216722000064/primary_doc.xml","form_type":"4"}},{"id":2463558,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-20T22:08:30.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":411616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock unit award (RSU) vests on March 15, 2022. Each restricted stock unit is equivalent to one share of the Company's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 411,616 RSUs."}],"balance_after":748949,"source":{"system":"sec-edgar","filing":"0001104659-21-151774","document":"tm2135922-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1542419/000110465921151774/tm2135922-4_4seq1.xml","form_type":"4"}},{"id":2523761,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2021-11-05T15:31:40.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of November 3, 2022, November 3, 2023 and November 3, 2024."}],"balance_after":70000,"derivative":{"exercise_price":8.35,"exercise_date":"2022-11-03","expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001042167-21-000079","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216721000079/primary_doc.xml","form_type":"4"}},{"id":2596746,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T17:02:31.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":4800,"price":6.7796,"value":32542.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is the weighted average transaction price.  The range of prices for such transactions is $6.77 to $6.78.  Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":9800,"source":{"system":"sec-edgar","filing":"0001042167-21-000061","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216721000061/primary_doc.xml","form_type":"4"}},{"id":2709163,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2021-05-18T19:47:12.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted for appointment to Board of Directors and committees thereof.  Options for one-third of the shares vest on each of May 14, 2022, May 14, 2023 and May 14, 2024."}],"balance_after":70000,"derivative":{"exercise_price":7.56,"exercise_date":"2022-05-14","expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001042167-21-000040","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216721000040/primary_doc.xml","form_type":"4"}},{"id":3273445,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units","published_at":"2020-02-13T21:31:43.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":110959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen."}],"balance_after":246576,"derivative":{"exercise_price":0,"expiration_date":"2025-02-12","underlying":"Common Stock","underlying_shares":110959},"source":{"system":"sec-edgar","filing":"0001104659-20-020235","document":"tm208004-1_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1542419/000110465920020235/tm208004-1_form4.xml","form_type":"4"}},{"id":3500029,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units","published_at":"2019-06-05T20:41:43.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":135617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen."}],"balance_after":135617,"derivative":{"exercise_price":0,"expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":135617},"source":{"system":"sec-edgar","filing":"0001144204-19-029899","document":"tv523097_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1542419/000114420419029899/tv523097_form4.xml","form_type":"4"}},{"id":3849393,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-08-09T01:48:47.000Z","date":"2018-08-07","kind":"gift","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 250,000 shares of restricted common stock will vest as follows: one-fourth on August 7, 2019, one-fourth on August 7, 2020, one-fourth on August 7, 2021, and one-fourth on August 7, 2022."}],"balance_after":807333,"source":{"system":"sec-edgar","filing":"0001144204-18-042962","document":"tv500470_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1542419/000114420418042962/tv500470_form4.xml","form_type":"4"}},{"id":3892071,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-06-15T17:19:17.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":5000,"price":4,"value":20000.0,"ownership":{"direct":true},"balance_after":557333,"source":{"system":"sec-edgar","filing":"0001144204-18-034375","document":"tv496576_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1542419/000114420418034375/tv496576_form4.xml","form_type":"4"}},{"id":3946159,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2018-05-04T15:09:10.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of May 2, 2019, May 2, 2020 and May 2, 2021."}],"balance_after":50000,"derivative":{"exercise_price":1.89,"exercise_date":"2019-05-02","expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001042167-18-000047","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216718000047/primary_doc.xml","form_type":"4"}},{"id":4197376,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2017-10-02T10:09:54.000Z","date":"2017-09-28","kind":"grant","acquired":true,"shares":4000,"price":5.2,"value":20800.0,"ownership":{"direct":true},"balance_after":552333,"source":{"system":"sec-edgar","filing":"0001144204-17-050793","document":"v476242_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1542419/000114420417050793/v476242_form4.xml","form_type":"4"}},{"id":4242938,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2017-08-04T15:43:53.000Z","date":"2017-08-02","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options for one-third of the shares vest on each of August 2, 2018, August 2, 2019 and August 2, 2020."}],"balance_after":45000,"derivative":{"exercise_price":1.2,"exercise_date":"2018-08-02","expiration_date":"2027-08-02","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001042167-17-000076","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216717000076/primary_doc.xml","form_type":"4"}},{"id":4321815,"issuer":{"id":7234,"kind":"organization","name":"VERU INC."},"owners":[{"id":49473,"kind":"person","name":"Lu Lucy","position":1,"cik":"0001542419","reported_name":"Lu Lucy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.01 per share","published_at":"2017-05-15T21:42:00.000Z","date":"2017-05-11","kind":"purchase","acquired":true,"shares":5000,"price":1,"value":5000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001042167-17-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863894/000104216717000037/primary_doc.xml","form_type":"4"}}]}